SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012536
Filing Date
2019-08-14
Accepted
2019-08-14 16:16:17
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 601716
2 ex4-1.htm EX-4.1 53593
3 ex31.htm EX-31 34429
4 ex32.htm EX-32 8917
  Complete submission text file 0001493152-19-012536.txt   3745424

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ocx-20190630.xml EX-101.INS 615477
6 XBRL SCHEMA FILE ocx-20190630.xsd EX-101.SCH 48884
7 XBRL CALCULATION FILE ocx-20190630_cal.xml EX-101.CAL 51865
8 XBRL DEFINITION FILE ocx-20190630_def.xml EX-101.DEF 181079
9 XBRL LABEL FILE ocx-20190630_lab.xml EX-101.LAB 332928
10 XBRL PRESENTATION FILE ocx-20190630_pre.xml EX-101.PRE 256306
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 191026586
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences